HamidSHMWhittamDMutchK, et al. What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients. J Neurol2017; 264(10): 2088–2094.
3.
NarayanRSimpsonAFritscheK, et al. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord2018; 25: 66–72.
4.
SundaramSNairSSJaganmohanD, et al. Relapsing lumbosacral myeloradiculitis: An unusual presentation of MOG antibody disease. Mult Scler2020; 26(4): 509–511.
5.
MacaronGOntanedaD. MOG-related disorders: A new cause of imaging-negative myelitis?Mult Scler2020; 26(4): 511–515.
6.
ChenJJFlanaganEPJitprapaikulsanJ, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: Clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol2018; 195: 8–15.
7.
DubeyDPittockSJKreckeKN, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol2019; 76: 301–309.
8.
SalamaSKhanMLevyM, et al. Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease. Mult Scler Relat Disord2019; 29: 15–22.
